In comparison, an siRNA-based knockdown of CBX2, another PRC1 protein, did not alleviate CCM phenotypes in HUVECs (Fig. 2K,K’,L), indicating that CBX2 is not involved in the morphology and pathophysiology in CCM2-depleted HUVECs. This evidence concerns the gene CCM2 and cerebral cavernous malformation.